NYSE$CNMD

Conmed Corp. · Q4 2025 earnings

Q4 2025 earnings · · After market close · Investor relations

Briefing

CNMD reported Q4 2025, revenue of $373.2M, net income of $16.7M, diluted EPS of $0.54.

For Q4 2025, CNMD reported revenue of $373.2M, net income of $16.7M, diluted EPS was $0.54, adjusted diluted EPS was $1.43. Management discusses segment performance, capital allocation, and outlook in the earnings release.

  • Revenue $373.2M.
  • Net income $16.7M.
  • Diluted EPS $0.54.
  • Adjusted diluted EPS $1.43.

Headline financials

Total Revenue

$373M

Previous: $346M+7.9%
EPS (adj)

$1.43

Previous: $1.34+6.7%
Sales Growth

7.9%

Previous: -0.8%+1087.5%
Sales Growth (Constant Currency)

7.1%

Previous: 7.1%+0.0%
Domestic Revenue Growth

1.4%

Previous: 0.0%
International Revenue Growth (Constant Currency)

15.4%

Previous: -1.6%+1062.5%
Adjusted Diluted EPS Growth

6.7%

Previous: 1.3%+400.0%
EPS Growth

-50.0%

Previous: 1.1%-4729.6%
Total CONMED Revenue Growth (Constant Currency)

7.1%

No prior period
General Surgery Revenue Growth (Constant Currency)

3.8%

No prior period
Orthopedic Surgery Revenue Growth (Constant Currency)

12.1%

No prior period
Single-use Products Revenue Growth (Constant Currency)

7.1%

No prior period
Capital Products Revenue Growth (Constant Currency)

7.3%

No prior period
Net Income

$16.7M

Previous: $33.8M-50.4%
Operating Income

$36.6M

Previous: $52.5M-30.2%
Gross Profit

$218M

Previous: $198M+10.1%

Revenue & EPS history

Conmed · Revenue · Quarterly

$373M

Q4 2025+7.9%vs Q4 2024
Beat estimate in 9 of 15 quarters(60%)
ActualEstimate

Revenue by segment

Conmed · $277M total across 2 segments · Q2 2022

  • General Surgery
    $157M
  • Orthopedic Surgery
    $120M

Forward guidance

The release discusses CNMD's outlook for upcoming periods, including capital allocation, operating priorities, and market risks.

Tailwinds

  • CNMD cites operational execution and demand trends supporting the outlook.
  • Balance sheet and capital actions aim to fund growth and shareholder returns.

Headwinds

  • Macro, pricing, and input-cost volatility could pressure margins.
  • Segment mix and one-time items may affect quarter-to-quarter comparability.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q4 2025

Historical avgQ4 2025

-0.0%

Avg return

Earnings day

+0.4%

Avg return

5 days after

+3.0%

Avg return

30 days after

45%

29 / 65 earnings

Positive

+16.5%

Q1 2025

Best reaction

-18.5%

Q3 2015

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+0.6%+1.9%-0.8%
Q4 2025-4.0%+0.3%+18.9%
Q3 2025-0.1%+0.6%-9.8%
Q1 2025+16.5%+13.8%+15.6%
Q4 2024-9.0%-12.1%-15.2%
Q3 2024+5.5%+9.0%+14.5%
Q2 2024-6.0%-5.6%+5.3%
Q1 2024-13.2%-5.7%+3.9%
Q4 2023-11.7%-13.0%-15.7%
Q3 2023-0.3%+3.1%+15.0%
Q2 2023-1.6%+0.8%-10.1%
Q1 2023+11.2%+9.2%+2.7%
Q4 2022+3.3%+6.4%+0.4%
Q3 2022-3.3%-1.0%+3.2%
Q2 2022-2.5%-4.5%-10.0%
Q1 2022-8.5%-19.2%-17.3%
Q4 2021+4.9%+11.0%+19.6%
Q3 2021+1.5%+2.0%-5.9%
Q2 2021+1.3%-0.2%-1.4%
Q1 2021+4.8%+7.0%+1.5%
Q4 2020-4.6%-6.1%+3.1%
Q3 2020+2.8%-3.9%+29.6%
Q2 2020+5.5%-0.4%+4.8%
Q1 2020+9.2%+0.5%+8.5%
Q4 2019-2.6%-4.7%-11.9%
Q3 2019+10.4%+12.9%+13.7%
Q2 2019+7.3%+4.5%+15.3%
Q1 2019+0.7%-2.6%+0.8%
Q4 2018+6.1%+4.9%+12.8%
Q3 2018-0.6%+1.3%+0.8%
Q2 2018+8.6%+5.5%+8.7%
Q1 2018+7.2%+5.3%+10.7%
Q4 2017+10.2%+7.1%+6.3%
Q3 2017+1.9%-2.7%+0.7%
Q2 2017-1.3%+1.3%-4.1%
Q1 2017+4.2%+6.9%+7.6%
Q4 2016-6.9%-4.0%-6.8%
Q3 2016+5.0%+3.3%+18.3%
Q2 2016-17.5%-16.9%-17.0%
Q1 2016-4.1%
Q4 2015-5.9%
Q3 2015-18.5%
Q2 2015-4.3%
Q1 2015+10.7%
Q4 2014-1.4%
Q3 2014+4.4%
Q2 2014-9.5%
Q1 2014-2.8%
Q4 2013+4.2%
Q3 2013-2.7%
Q2 2013+2.8%
Q1 2013-2.7%
Q4 2012+4.6%
Q3 2012+0.3%
Q2 2012-0.4%
Q1 2011+0.8%
Q1 2012-2.1%
Q1 2010-0.2%
Q4 2009-0.2%
Q4 2011-0.2%
Q3 2010-1.8%
Q3 2011-1.8%
Q2 2011-2.3%
Q4 2010-2.3%
Q2 2010-2.3%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro